Article Text

Download PDFPDF

PO.2.50 Utility in clinical practice of anti-dsdna autoantibodies vs antidna crithidia luciliae in the diagnosis of systemic lupus erythematosus
  1. V Ortiz-Santamaria1,
  2. A Nack2,
  3. J Climent-Martí3,
  4. À Prior-Español2,
  5. L Mateo Soria2,
  6. M Martínez-Morillo2,
  7. L Gifre2,
  8. M Aparicio-Espinar2,
  9. A Riveros2,
  10. C Sangüesa2,
  11. J Camins-Fàbregas1,
  12. I Casafont-Solé2,
  13. M Aparicio-Rovira2,
  14. I Peralta-Garcia2 and
  15. S Holgado2
  1. 1Rheumatology Unit ~ Granollers ~ Spain
  2. 2Rheumatology Department ~ Badalona ~ Spain
  3. 3Immunology Department ~ Badalona ~ Spain


Introduction Double-stranded-DNA antibodies (antiDNAds) are the most frequently detected serological markers in patients with Systemic Lupus Erythematosus (SLE). In clinical practice, it is usually determined by the ELISA technique with a specificity of 91–96%. There is another technique with a specificity of 98–100%, which is performed by immunofluorescence (IF) using Crithidia lucilae (CL) parasite.

Purpose To determine anti-DNA by CL in patients with ANA and positive anti-DNAds by ELISA.

To analyse whether there is a relationship between the patients who meet the 2019-ACR-EULAR classification criteria for SLE, and the positivity of anti-DNA by CL.

Methods Bicentric retrospective observational study (Hospital Universitari Germans Trias i Pujol and Hospital General de Granollers).

Patients with ANA ≥1/320 and DNA by ELISA >100IU/mL between 2018–2019 were collected. All underwent the IF CL test. The classification criteria for SLE ACR-EULAR 2019 were applied.

Conclusions Anti-DNA CL test could be useful to discriminate patients with anti-DNA positive test by ELISA and low suspicion of SLE. In our series 95.7% of the patients with CL negative test did not meet SLE criteria.

SLE in elderly behaves different than in younger patients. In our population:

⋄ Age over 65 years: anti-DNA CL test does not allow discrimination between those who meet the SLE criteria and those who don’t.

⋄ Age under 65 years: anti-DNA CL test presents a high correlation with the clinical and analytical data of the patients.

This test could be very useful in clinical practice to complement diagnostic criteria in SLE patients <65 years of age.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.